• SENSEX 76,917.85
    1,225.07 (+1.62%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,814.50 1,878.00(%)
  • Jio Platforms
    1,440.80 1,490.00(%)
  • Bharti Airtel
    2,080.70 2,174.70(%)
  • Reliance Industries
    1,307.00 1,611.20(%)
  • BLS Polymers
    285.25 285.25(%)
  • Solar Industries
    20,860.00 22,630.05(%)
  • Multi Comm. Exc.
    3,537.00 3,537.00(%)
  • Aegis Logistics
    1,253.90 1,528.00(%)
  • SBI
    961.35 933.85(%)
  • HDFC Bank
    725.70 1,017.90(%)
  • Oil India
    451.30 395.75(%)
  • Garden Reach Sh.
    2,235.00 3,338.90(%)
  • Divi's Lab.
    10,035.00 10,035.00(%)
  • M & M Fin. Serv.
    267.15 415.00(%)
  • Sagility
    41.98 35.82(%)
  • SFC Enviro.
    424.85 424.85(%)
  • Mankind Pharma
    2,523.70 2,640.30(%)
  • M & M
    2,910.95 3,840.00(%)
  • Kanohar Elect.
    1,165.90 1,210.00(%)
  • Laurus Labs
    2,252.50 913.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Shree Ganesh Biotech India Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 41344.0
  • ISIN : INE051N01026
0.46 0 (2.22%)
  • As on 03 Nov 2026 (EOD)
  • Today’s Low

    0.44
  • Today’s High

    0.48
  • Open

    0.45
  • Perv Close

    0.45
  • 52W Low

    0.40
  • 52W High

    0.75

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    18.34

  • Div & Yield %

    0.00

  • Book Value(₹)

    1.60

  • Debt-Equity Ratio

    2.22

  • AGM Date

    03-Nov-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    18.34

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    39.86

  • BV (₹)

    1.60

  • Sales( ₹ in Cr.)

    4.97

  • NP (in Cr.)

    0.61

  • NP Var(%)

    78.0

  • Div%

    0.0

  • CPS (₹)

    0.00

  • EPS (₹)

    0.00

  • Traded Value (₹ in Lakhs)

    17.94

  • 52 Week High

    0.75

  • 52 Week Low

    0.40

  • Price BSE

    0.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    17.94

  • P/C Ratio

    0.00

  • P/E Ratio

    0.00

  • Price Vs.BV

    0.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 4.97 22.96 20.28 62.45 72.64 17.21
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 4.97 22.96 20.28 62.45 72.64 17.21
Other Income 1.47 1.44 1.06 0.56 0.05 0.00
Stock Adjustments 8.84 2.89 0.00 0.00 0.00 0.00
Total Income 15.28 27.29 21.34 63.01 72.69 17.21
EXPENDITURE :            
Raw Materials 13.90 25.53 20.03 59.63 68.84 16.33
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 0.16 0.10 0.18 0.22 0.25 0.08
Other Manufacturing Expenses 0.00 0.00 0.00 0.00 0.00 0.00
Selling and Administration Expenses 0.39 0.32 0.26 0.45 0.11 0.09
Miscellaneous Expenses 0.32 0.95 0.00 0.00 0.00 0.28
Employee Benefit Expenses 0.16 0.10 0.18 0.22 0.25 0.08
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 14.77 26.90 20.48 60.31 69.20 16.78
Operating Profit 0.51 0.39 0.86 2.71 3.50 0.43
Interest 0.00 0.00 0.00 0.00 0.00 0.00
Gross Profit 0.51 0.39 0.86 2.71 3.50 0.43
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax 0.51 0.39 0.86 2.71 3.50 0.43
Current Tax 0.14 0.11 0.23 0.68 0.97 0.11
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 0.38 0.28 0.62 2.04 2.53 0.32
Extraordinary Items -0.23 -0.07 0.00 0.00 0.00 -0.21
Adjusted Net Profit 0.61 0.35 0.62 2.04 2.53 0.53
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 17.96 17.68 17.06 15.02 12.50 12.18
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 18.34 17.96 17.68 17.06 15.02 12.50
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.01 0.01 0.02 0.05 0.13 0.16
Earnings Per Share(Adj)-Unit Curr 0.01 0.01 0.02 0.05 0.07 0.01
Book Value 1.60 1.59 1.58 1.56 3.03 29.00
Book Value(Adj)-Unit Curr 1.60 1.59 1.58 1.56 1.52 1.45

Shareholding Pattern

  • Public Share Holding

    100.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 5,664,940 1.42 5,664,940 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 5,664,940 1.42 5,664,940 1
2] Non Institution
Bodies Corporate 1,134,293 0.28 1,134,293 28
Clearing Members 60,701 0.02 60,701 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 6,712,327 1.68 6,712,327 298
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 4,526,907 1.14 4,526,907 256
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 71,272,530 17.88 71,272,530 128
Individuals holding nominal share capital up to Rs. 1 lakh 309,230,302 77.57 308,537,302 177,921
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 392,959,060 98.58 392,266,060 178,636
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 398,624,000 100.00 397,931,000 178,637

Company Background

Shree Ganesh Biotech India LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Shree Ganesh Biotech India Ltd
  • BSE Code : 41344.0
  • ISIN : INE051N01026
  • Incorporation Year

    1982

  • Registered Office

    6 Flr Premises-602 Mahavir Apt
    2 Aushutosh Mukherjee Road, Kolkata,
    West Bengal-700020

  • Telephone

  • FAX

  • Chairman

    Aman Patel

  • Managing Director

  • Company Secretary

    Namita Acharya

  • Auditor

    Bipin & co

  • Face Value

    1

  • Listing

    BSE

  • Registrar

    Niche Technologies Pvt Ltd
    D-511 Bagree Market,
    5th Floor,71 B R B Basu Road
    Mumbai - Kolkata - 700001

Shree Ganesh Biotech India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Shree Ganesh Bio 0.46 6.44 4.97 -46.00 1.32
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77